A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer

NCT05656092 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

199

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Ulcer

Interventions

DRUG: HIP0612
DRUG: HPP2202
DRUG: RLD2204
DRUG: HPP2201

Sponsor

Hanmi Pharmaceutical Company Limited